Nuvation Bio Inc.
NUVB
$8.11
$0.648.57%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 26.75M | 14.36M | 10.96M | 7.87M | 2.16M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 26.75M | 14.36M | 10.96M | 7.87M | 2.16M |
| Cost of Revenue | 12.24M | 10.40M | 9.17M | 7.08M | 2.86M |
| Gross Profit | 14.51M | 3.95M | 1.79M | 795.00K | -700.00K |
| SG&A Expenses | 137.37M | 119.60M | 97.27M | 69.23M | 48.58M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 259.72M | 238.99M | 217.32M | 175.43M | 136.61M |
| Operating Income | -232.97M | -224.64M | -206.36M | -167.56M | -134.45M |
| Income Before Tax | -217.48M | -202.90M | -606.38M | -567.94M | -532.28M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -217.48 | -202.90 | -606.38 | -567.94 | -532.28 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -217.48M | -202.90M | -606.38M | -567.94M | -532.28M |
| EBIT | -232.97M | -224.64M | -206.36M | -167.56M | -134.45M |
| EBITDA | -231.55M | -223.59M | -205.43M | -166.87M | -133.93M |
| EPS Basic | -0.64 | -0.63 | -2.34 | -2.25 | -2.17 |
| Normalized Basic EPS | -0.40 | -0.39 | -0.38 | -0.32 | -0.27 |
| EPS Diluted | -0.64 | -0.63 | -2.35 | -2.26 | -2.17 |
| Normalized Diluted EPS | -0.40 | -0.39 | -0.38 | -0.32 | -0.27 |
| Average Basic Shares Outstanding | 1.36B | 1.29B | 1.19B | 1.07B | 956.34M |
| Average Diluted Shares Outstanding | 1.36B | 1.29B | 1.19B | 1.07B | 956.34M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |